List of Tables
Table 1. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Product Type & Application
Table 12. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bruton’s Tyrosine Kinase (BTK) Inhibitor as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2019-2024) & (K Units)
Table 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2019-2024)
Table 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2025-2030) & (K Units)
Table 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2025-2030)
Table 21. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2019-2024)
Table 23. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2025-2030)
Table 25. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2024) & (K Units)
Table 27. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2025-2030) & (K Units)
Table 28. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2024) & (K Units)
Table 32. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2025-2030) & (K Units)
Table 33. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Type (2019-2024)
Table 51. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Type (2025-2030)
Table 52. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2019-2024)
Table 53. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2025-2030)
Table 54. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2019-2024)
Table 57. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2025-2030)
Table 58. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Application (2019-2024)
Table 61. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Application (2025-2030)
Table 62. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2019-2024)
Table 63. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2025-2030)
Table 64. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2019-2024)
Table 67. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2025-2030)
Table 68. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2025-2030)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Principia Biopharma Corporation Information
Table 81. Principia Biopharma Description and Business Overview
Table 82. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 84. Principia Biopharma Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 89. Merck Recent Developments/Updates
Table 90. Sunesis Pharmaceuticals Corporation Information
Table 91. Sunesis Pharmaceuticals Description and Business Overview
Table 92. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 94. Sunesis Pharmaceuticals Recent Developments/Updates
Table 95. BeiGene Corporation Information
Table 96. BeiGene Description and Business Overview
Table 97. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 99. BeiGene Recent Developments/Updates
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 104. Novartis Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Celgene Corporation Corporation Information
Table 111. Celgene Corporation Description and Business Overview
Table 112. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 114. Celgene Corporation Recent Developments/Updates
Table 115. Loxo Corporation Information
Table 116. Loxo Description and Business Overview
Table 117. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 119. Loxo Recent Developments/Updates
Table 120. ArQule Corporation Information
Table 121. ArQule Description and Business Overview
Table 122. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 124. ArQule Recent Developments/Updates
Table 125. Hengrui Corporation Information
Table 126. Hengrui Description and Business Overview
Table 127. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
Table 129. Hengrui Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Bruton’s Tyrosine Kinase (BTK) Inhibitor Distributors List
Table 133. Bruton’s Tyrosine Kinase (BTK) Inhibitor Customers List
Table 134. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Trends
Table 135. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers
Table 136. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Challenges
Table 137. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bruton’s Tyrosine Kinase (BTK) Inhibitor
Figure 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Type in 2023 & 2030
Figure 4. Acalabrutinib Product Picture
Figure 5. Zanubrutinib Product Picture
Figure 6. Ibrutinib Product Picture
Figure 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Application in 2023 & 2030
Figure 9. Tumor
Figure 10. Autoimmunity
Figure 11. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size (2019-2030) & (US$ Million)
Figure 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (2019-2030) & (K Units)
Figure 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Price (US$/Unit) & (2019-2030)
Figure 15. Bruton’s Tyrosine Kinase (BTK) Inhibitor Report Years Considered
Figure 16. Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Manufacturers in 2023
Figure 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Bruton’s Tyrosine Kinase (BTK) Inhibitor Players: Market Share by Revenue in 2023
Figure 19. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2019-2030)
Figure 22. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2019-2030)
Figure 26. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2019-2030)
Figure 27. Germany Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2019-2030)
Figure 34. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2019-2030)
Figure 45. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Type (2019-2030)
Figure 55. Global Revenue Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Type (2019-2030)
Figure 56. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Application (2019-2030)
Figure 58. Global Revenue Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Application (2019-2030)
Figure 59. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2019-2030)
Figure 60. Bruton’s Tyrosine Kinase (BTK) Inhibitor Value Chain
Figure 61. Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed